NOTCH4
Basic information
Region (hg38): 6:32194843-32224067
Previous symbols: [ "INT3" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NOTCH4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 21 | 26 | ||||
missense | 90 | 10 | 106 | |||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 5 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 3 | 2 | 5 | |||
non coding | 46 | 46 | ||||
Total | 0 | 0 | 91 | 12 | 81 |
Variants in NOTCH4
This is a list of pathogenic ClinVar variants found in the NOTCH4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-32195497-G-A | Benign (May 05, 2021) | |||
6-32195529-G-A | not specified | Uncertain significance (Oct 06, 2021) | ||
6-32195532-T-A | not specified | Uncertain significance (Jul 19, 2023) | ||
6-32195534-A-G | not specified | Uncertain significance (Mar 20, 2024) | ||
6-32195631-G-A | not specified | Uncertain significance (Feb 06, 2024) | ||
6-32195699-G-A | not specified | Uncertain significance (Jan 26, 2022) | ||
6-32195711-C-G | not specified | Uncertain significance (Aug 09, 2021) | ||
6-32195753-C-G | not specified | Uncertain significance (May 31, 2023) | ||
6-32195756-C-T | not specified | Uncertain significance (Aug 08, 2022) | ||
6-32195764-A-C | Benign (May 05, 2021) | |||
6-32195798-A-G | not specified | Uncertain significance (Apr 20, 2024) | ||
6-32195837-C-T | not specified | Uncertain significance (Aug 11, 2022) | ||
6-32195887-C-T | Benign (May 05, 2021) | |||
6-32195901-C-A | not specified | Uncertain significance (Jan 16, 2024) | ||
6-32195952-G-T | not specified | Uncertain significance (Nov 01, 2021) | ||
6-32195985-C-T | not specified | Uncertain significance (Jul 07, 2022) | ||
6-32196022-T-C | Benign (May 05, 2021) | |||
6-32196044-G-T | not specified | Uncertain significance (May 14, 2024) | ||
6-32196153-G-C | Likely benign (May 07, 2018) | |||
6-32196353-C-G | not specified | Uncertain significance (Apr 23, 2024) | ||
6-32196888-CT-C | Benign (May 14, 2021) | |||
6-32196982-C-T | not specified | Uncertain significance (Dec 15, 2022) | ||
6-32197022-C-T | Benign (Apr 24, 2018) | |||
6-32197042-C-T | Likely benign (Jul 23, 2018) | |||
6-32197063-G-A | not specified | Uncertain significance (Jan 18, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NOTCH4 | protein_coding | protein_coding | ENST00000375023 | 30 | 29225 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.05e-23 | 1.00 | 125564 | 0 | 184 | 125748 | 0.000732 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.14 | 937 | 1.14e+3 | 0.822 | 0.0000616 | 12764 |
Missense in Polyphen | 379 | 460.99 | 0.82215 | 5314 | ||
Synonymous | 3.02 | 378 | 460 | 0.821 | 0.0000252 | 4191 |
Loss of Function | 3.56 | 51 | 86.8 | 0.588 | 0.00000432 | 977 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00220 | 0.00213 |
Ashkenazi Jewish | 0.000303 | 0.000298 |
East Asian | 0.000827 | 0.000816 |
Finnish | 0.000243 | 0.000231 |
European (Non-Finnish) | 0.000660 | 0.000615 |
Middle Eastern | 0.000827 | 0.000816 |
South Asian | 0.00107 | 0.00105 |
Other | 0.000671 | 0.000652 |
dbNSFP
Source:
- Function
- FUNCTION: Functions as a receptor for membrane-bound ligands Jagged1, Jagged2 and Delta1 to regulate cell-fate determination. Upon ligand activation through the released notch intracellular domain (NICD) it forms a transcriptional activator complex with RBPJ/RBPSUH and activates genes of the enhancer of split locus. Affects the implementation of differentiation, proliferation and apoptotic programs. May regulate branching morphogenesis in the developing vascular system (By similarity). {ECO:0000250}.;
- Pathway
- Breast cancer - Homo sapiens (human);Thyroid hormone signaling pathway - Homo sapiens (human);MicroRNAs in cancer - Homo sapiens (human);Pathways in cancer - Homo sapiens (human);Notch signaling pathway - Homo sapiens (human);Human papillomavirus infection - Homo sapiens (human);NOTCH-Ncore;Neural Crest Differentiation;Notch Signaling Pathway;Canonical and Non-canonical Notch signaling;VEGFA-VEGFR2 Signaling Pathway;Role of Osx and miRNAs in tooth development;EMT transition in Colorectal Cancer;Notch Signaling Pathway;Notch Signaling Pathway;Notch;Signal Transduction;Gene expression (Transcription);Generic Transcription Pathway;RNA Polymerase II Transcription;Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor;Notch-HLH transcription pathway;Notch;NICD traffics to nucleus;Pre-NOTCH Processing in the Endoplasmic Reticulum;Pre-NOTCH Processing in Golgi;Pre-NOTCH Expression and Processing;Signaling by NOTCH4;Signaling by NOTCH;A third proteolytic cleavage releases NICD;Notch signaling pathway
(Consensus)
Intolerance Scores
- loftool
- 0.138
- rvis_EVS
- 0.15
- rvis_percentile_EVS
- 64.33
Haploinsufficiency Scores
- pHI
- 0.374
- hipred
- Y
- hipred_score
- 0.595
- ghis
- 0.499
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.946
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | Medium | High |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Notch4
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; embryo phenotype; normal phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); homeostasis/metabolism phenotype; growth/size/body region phenotype;
Gene ontology
- Biological process
- branching involved in blood vessel morphogenesis;cell fate determination;morphogenesis of a branching structure;endothelial cell morphogenesis;vasculature development;transcription initiation from RNA polymerase II promoter;positive regulation of transcription of Notch receptor target;hemopoiesis;cell differentiation;mammary gland development;miRNA mediated inhibition of translation;wound healing;negative regulation of cell differentiation;negative regulation of endothelial cell differentiation;positive regulation of Notch signaling pathway;positive regulation of transcription, DNA-templated
- Cellular component
- Golgi membrane;extracellular region;nucleus;nucleoplasm;endoplasmic reticulum membrane;cytosol;plasma membrane;integral component of plasma membrane;cell surface
- Molecular function
- calcium ion binding;protein binding;signaling receptor activity;protein heterodimerization activity